Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation Protocol for the Demonstration of Safety and Efficacy of VeSTAL Weight Loss Device in Human Subjects. Randomized Study of VeSTAL in Patients Who Are Overweight

NCT03640286 is registered in ClinicalTrials.gov with Neurovalens Ltd. as lead sponsor.

NCT NCT03640286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03640286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation Protocol for the Demonstration of Safety and Efficacy of VeSTAL Weight Loss Device in Human Subjects. Randomized Study of VeSTAL in Patients Who Are Overweight
Lead sponsor
Neurovalens Ltd.
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2019
Completion date
April 26, 2022
Enrollment
241 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

obesity